NASDAQ: MRNAModerna Inc Stock Ownership - Who owns Moderna?
Insider buying vs selling
Have Moderna Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen Hoge | President | 2024-04-15 | 15,000 | $105.02 | $1.58MSell |
| Noubar Afeyan | Director | 2024-04-10 | 748 | $108.56 | $81.21kSell |
| Noubar Afeyan | Director | 2024-04-10 | 6,351 | $106.59 | $676.98kSell |
| Noubar Afeyan | Director | 2024-04-10 | 7,512 | $107.31 | $806.14kSell |
| Noubar Afeyan | Director | 2024-04-10 | 389 | $109.36 | $42.54kSell |
| James M. Mock | Chief Financial Officer | 2024-04-08 | 705 | $101.93 | $71.86kSell |
| Noubar Afeyan | Director | 2024-04-03 | 3,167 | $100.66 | $318.77kSell |
| Noubar Afeyan | Director | 2024-04-03 | 200 | $97.47 | $19.49kSell |
| Noubar Afeyan | Director | 2024-04-03 | 100 | $104.15 | $10.42kSell |
| Noubar Afeyan | Director | 2024-04-03 | 2,702 | $103.64 | $280.04kSell |
MRNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MRNA insiders and whales buy or sell their stock.
MRNA Shareholders
What type of owners hold Moderna Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Noubar Afeyan | 14.05% | 53,670,087 | $5.55B | Insider |
| Baillie Gifford Co | 11.95% | 45,654,527 | $4.72B | Institution |
| Vanguard Group Inc | 8.87% | 33,907,072 | $3.51B | Institution |
| Blackrock Inc | 6.62% | 25,301,692 | $2.62B | Institution |
| State Street Corp | 3.83% | 14,623,723 | $1.51B | Institution |
| Stephane Bancel | 3.15% | 12,025,104 | $1.24B | Insider |
| Robert Langer | 3.02% | 11,551,753 | $1.19B | Insider |
| Flagship Pioneering Inc | 2.53% | 9,666,038 | $999.85M | Institution |
| Theleme Partners LLP | 1.92% | 7,349,456 | $760.23M | Institution |
| Wellington Management Group LLP | 1.89% | 7,225,579 | $747.41M | Institution |
MRNA vs Biotech Stocks
Moderna Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.